U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392853) titled 'Investigation of the Effectiveness of Prophylactic NPWT (ciNPWT) in High-risk Diabetic Patie... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07394504) titled 'Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diab... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393204) titled 'Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL' on Dec. 22, 2025. ... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392814) titled 'Single-Center Phase 1 Study With Escalating Doses of Tocilizumab in Combination With Venetoc... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07394920) titled 'The Role of Sodium Bicarbonate Enema in Improving Constipation and Reducing Uremic Toxins in... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393295) titled 'Efficacy and Tolerability of TENS in Endometriosis-related Pain' on Jan. 23. Brief Summary:... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392060) titled 'A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice o... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393932) titled 'MND Together: Phase 1' on Jan. 15. Brief Summary: This project consists of two workstreams,... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393698) titled 'Intervention to Improve 24-Hour Movement Behaviors in University Students' on Jan. 16. Brie... Read More
U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392255) titled 'An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe an... Read More